The challenges of trials of antibiotics for pneumonia in low-income countries

The Lancet Respiratory Medicine

Volumn 2, Issue 12, 2014, Pages 952-954

  Mulholland, Kim ^a   Carlin, John B ^b,d   Duke, Trevor ^c   Weber, Martin ^e  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

BACTERIAL PNEUMONIA; BREATHING; DISEASE SEVERITY; FATALITY; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; LOWEST INCOME GROUP; MORTALITY; NOTE; PNEUMONIA; POPULATION RESEARCH; SOUTH AFRICA; THORAX WALL; CLINICAL TRIAL (TOPIC); DEVELOPING COUNTRY; PNEUMONIA, BACTERIAL; POVERTY; SAMPLE SIZE;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; DEVELOPING COUNTRIES; HUMANS; PNEUMONIA, BACTERIAL; POVERTY; SAMPLE SIZE;

EID: 84919623777     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(14)70273-5     Document Type: Note

References (15)

1. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic review for 2010 with time trends since 2000. Lancet 2012, 379:2151-2161.
2. Hospital care for children: guidelines for the management of common illnesses with limited resources 2013, WHO, World Health Organization, Geneva.
3. Bari A, Sadruddin S, Khan A, et al. Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial. Lancet 2011, 378:1796-1803.
4. Soofi S, Ahmed S, Fox MP, et al. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial. Lancet 2012, 379:729-737.
5. Addo-Yobo E, Anh DD, El-Sayed HF, et al. Outpatient treatment of children with severe pneumonia with oral amoxycillin in four countries: the MASS study. Trop Med Int Health 2011, 16:995-1006.
6. Hazir T, Fox LM, Nisar YB, et al. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Lancet 2008, 371:49-56.
7. Management of pneumonia in community settings WHO/UNICEF Joint Statement, (accessed Nov 13, 2014). http://www.who.int/maternal_child_adolescent/documents/child-pneumonia-treatment/en/.
8. Nair H, Simoes EAF, Rudan I, et al. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet 2013, 381:1380-1390.
9. Sehgal V, Sethi GR, Sachdev HP, Satanarayana L Predictors of mortality in subjects hospitalised with acute lower respiratory tract infections. Indian Pediatr 1997, 34:213-219.
10. Banejeh SM, al-Sunbali NN, al-Sanahani SH Clinical characteristics and outcome of children aged under 5 years hospitalised with severe pneumonia in Yemen. Ann Trop Paediatr 1997, 17:321-326.
11. Tiewsoh K, Lodha R, Pandey RM, Broor S, Kalaivani M, Kabra SK Factors determining the outcome of children hospitalized with severe pneumonia. BMC Pediatrics 2009, 9:15.
12. Greengard J, Raycraft WB, Motel WG Effect of chemotherapy on pneumonia in infants under one year of age. Am J Dis Child 1943, 62:730-742.
13. Sazawal S, Black RE Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis 2003, 3:547-556.
14. Reed C, Madhi SA, Klugman KP, et al. Development of the Respiratory Index of Severity in Children (RISC) Score among young children with respiratory infections in South Africa. PLoS One 2012, 7:e27793.
15. Simplified regimens for management of neonates and young infants with severe infection when hospital admission is not possible: study protocol for a randomized, open-label equivalence trial. Pediatr Infect Dis J 2014, 32(suppl 1):S26-S32. AFRIcan NEonatal Sepsis Trial Group.